BioCentury
ARTICLE | Company News

Bracco Imaging S.p.A., Marillion deal

November 17, 2008 8:00 AM UTC

Bracco granted Marillion exclusive, worldwide rights to develop and commercialize 177Lu-AMBA to treat hormone-resistant prostate cancer (HRPC) and advanced breast cancer. The radiotherapeutic combined...